HE 20.6524:76/V.1-2
|
Ephedra and ephedrine for weight loss and athletic performance enhancement clinical efficacy and side effects / |
1 |
HE 20.6524:77/SUM
|
Management of treatment-resistant epilepsy |
1 |
HE 20.6524:77/V.1-2
|
Management of treatment-resistant epilepsy |
1 |
HE 20.6524:78
|
Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer |
1 |
HE 20.6524:78/SUM
|
Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer |
1 |
HE 20.6524:79
|
Diffusion and dissemination of evidence-based cancer control interventions |
1 |
HE 20.6524:79/SUM
|
Diffusion and dissemination of evidence-based cancer control interventions |
1 |
HE 20.6524:80
|
Results of systematic review of research on diagnosis and treatment of coronary heart disease in women |
1 |
HE 20.6524:80/SUM
|
Results of systematic review of research on diagnosis and treatment of coronary heart disease in women |
1 |
HE 20.6524:81
|
Diagnosis and treatment of coronary heart disease in women systematic reviews of evidence on selected topics / |
1 |
HE 20.6524:81/SUM
|
Diagnosis and treatment of coronary heart disease in women systematic reviews of evidence on selected topics : summary. |
1 |
HE 20.6524:82
|
Pharmacologic management of heart failure and left ventricular systolic dysfunction effect in female, black, and diabetic patients, and cost-effectiveness / |
1 |
HE 20.6524:82/SUM
|
Pharmacologic management of heart failure and left ventricular systolic dysfunction effect in female, black, and diabetic patients, and cost-effectiveness. |
1 |
HE 20.6524:83
|
Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease |
1 |
HE 20.6524:83/SUM
|
Effect of supplemental antioxidants vitamin C, vitamin E, and coenzyme Q10 for the prevention and treatment of cardiovascular disease |
1 |
HE 20.6524:84
|
Use of glycated hemoglobin and microabuminuria in the monitoring of diabetes mellitus |
1 |
HE 20.6524:84/SUM
|
Use of glycated hemoglobin and microabuminuria in the monitoring of diabetes mellitus |
1 |
HE 20.6524:85
|
Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke |
1 |
HE 20.6524:85/SUM
|
Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke |
1 |
HE 20.6524:86
|
Total knee replacement |
1 |